XsunX Inc Share Price OTC Bulletin Board
Equities
US98385L1026
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.17M 173M |
---|---|---|---|---|---|
Net income 2022 | -1M -79.65M | Net income 2023 | -4M -319M | EV / Sales 2022 | - |
Net Debt 2022 | 1.41M 112M | Net Debt 2023 | 2.36M 188M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.16
x | P/E ratio 2023 |
-0.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.82% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 14/10/20 | |
Neil Laird
DFI | Director of Finance/CFO | 70 | 09/09/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 14/10/20 | |
Jason Anderson
BRD | Director/Board Member | 50 | 17/03/22 |
John Cassarini
CHM | Chairman | 57 | 13/03/22 |
1st Jan change | Capi. | |
---|---|---|
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+45.09% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |